Literature DB >> 414235

Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, and Y.

J D Farquhar, W A Hankins, A N Desanctis, J L Demeio, D P Metzgar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 414235     DOI： 10.3181/00379727-157-39995

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  6 in total

1.  Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.

Authors:  E C Beuvery; F Miedema; R van Delft; J Haverkamp
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

2.  Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines.

Authors:  J M Griffiss; B L Brandt; D D Broud
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

3.  Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults.

Authors:  J M Griffiss; B L Brandt; P L Altieri; G B Pier; S L Berman
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

Review 4.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

5.  Meningococcal disease in Scandinavia.

Authors:  H Peltola; K Jónsdóttir; A Lystad; C J Sievers; I Kallings
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-29

6.  Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.

Authors:  F Ambrosch; G Wiedermann; P Crooy; A M George
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.